# Venezuela Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Venezuela HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Venezuela (VEN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $11.0M
- Products: 33
- Buyer markets: 20
- Average CAGR: -8.1%
- Global sector size: $431.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $258.4B | $1.3M | $94.4B | -7.3% | 16 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $24.8B | $78.1K | $15.8B | -26.3% | 8 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $18.4B | $20.8K | $10.4B | +13.7% | 4 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $6.8B | $5.5K | $9.6B | -3.6% | 2 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $8.4B | $5.6K | $8.8B | +98.4% | 2 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $8.3B | $20.1K | $8.5B | -65.2% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $15.1B | $8.1K | $7.8B | +18.4% | 4 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $16.3B | $2.2K | $6.9B | -3.2% | 3 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.2B | $2.8K | $5.7B | -8.0% | 2 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $6.9B | $21.9K | $5.0B | +22.4% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $16.8K | $5.0B | -12.8% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $1.8K | $4.6B | -18.8% | 3 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $5.7B | $5.4M | $3.9B | -13.7% | 3 | +0.3% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $8.3K | $2.2B | -14.8% | 2 | +0.0% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $1.5B | $312.6 | $2.1B | -36.2% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $110.6 | $2.0B | -30.0% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $146.9K | $1.9B | +16.9% | 1 | +0.0% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.6B | $5.8K | $1.8B | -10.8% | 1 | +0.0% |
| HS 284190 - Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $1.7B | $3.5K | $1.7B | -18.3% | 1 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $25.2 | $1.7B | -31.5% | 1 | +0.0% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.1B | $2.2 | $1.4B | -38.3% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $2.7K | $1.4B | -12.6% | 1 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.6B | $14.7K | $1.4B | +10.9% | 1 | +0.0% |
| HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.6B | $267.7K | $1.4B | -55.5% | 1 | +0.0% |
| HS 310221 - Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | $965.4M | $1.7M | $1.3B | +69.7% | 1 | +0.6% |
| HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $885.3K | $1.3B | -5.3% | 1 | +0.3% |
| HS 290250 - Cyclic hydrocarbons: styrene | $768.8M | $340.1 | $1.1B | -91.2% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $10.4 | $1.0B | -25.2% | 1 | +0.0% |
| HS 310559 - Fertilizers, mineral or chemical: containing the two fertilizing elements nitrogen and phosphorus, other than nitrates and phosphates | $1.2B | $439.7K | $961.6M | +15.2% | 1 | +0.1% |
| HS 290220 - Cyclic hydrocarbons: benzene | $1.4B | $683.8K | $894.4M | -9.3% | 1 | +0.1% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $16.9K | $841.5M | +14.2% | 1 | +0.0% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $820.5M | $281.7 | $838.8M | -91.2% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $36.7 | $803.3M | -15.3% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $58.4B calculated opportunity across 16 products.
- Switzerland, Liechtenstein (CHE): $31.0B calculated opportunity across 2 products.
- Germany (DEU): $17.8B calculated opportunity across 7 products.
- Belgium (BEL): $16.1B calculated opportunity across 3 products.
- Mexico (MEX): $12.6B calculated opportunity across 7 products.
- Spain (ESP): $11.2B calculated opportunity across 6 products.
- Italy (ITA): $10.7B calculated opportunity across 3 products.
- China (CHN): $9.0B calculated opportunity across 3 products.
- Canada (CAN): $8.0B calculated opportunity across 4 products.
- Netherlands (NLD): $6.7B calculated opportunity across 2 products.
- Brazil (BRA): $6.6B calculated opportunity across 5 products.
- United Kingdom (GBR): $6.1B calculated opportunity across 2 products.

## Growth stars

- HS 300220: +98.4% average CAGR, $8.8B calculated opportunity.
- HS 310221: +69.7% average CAGR, $1.3B calculated opportunity.
- HS 293399: +22.4% average CAGR, $5.0B calculated opportunity.
- HS 300439: +18.4% average CAGR, $7.8B calculated opportunity.
- HS 382319: +16.9% average CAGR, $1.9B calculated opportunity.
- HS 310559: +15.2% average CAGR, $961.6M calculated opportunity.
- HS 300449: +14.2% average CAGR, $841.5M calculated opportunity.
- HS 300212: +13.7% average CAGR, $10.4B calculated opportunity.
- HS 284410: +10.9% average CAGR, $1.4B calculated opportunity.
- HS 330499: -3.2% average CAGR, $6.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 16 buyer markets, $94.4B calculated opportunity.
- HS 382499: 8 buyer markets, $15.8B calculated opportunity.
- HS 300212: 4 buyer markets, $10.4B calculated opportunity.
- HS 300439: 4 buyer markets, $7.8B calculated opportunity.
- HS 330499: 3 buyer markets, $6.9B calculated opportunity.
- HS 330300: 3 buyer markets, $5.0B calculated opportunity.
- HS 382200: 3 buyer markets, $4.6B calculated opportunity.
- HS 281820: 3 buyer markets, $3.9B calculated opportunity.
- HS 330210: 2 buyer markets, $9.6B calculated opportunity.
- HS 300220: 2 buyer markets, $8.8B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.